Presentation is loading. Please wait.

Presentation is loading. Please wait.

MN-enriched miRNAs are depleted temporally in ALS rodent model and human patient spinal cord. MN-enriched miRNAs are depleted temporally in ALS rodent.

Published byElina Järvenpää Modified over 5 years ago

Similar presentations

Presentation on theme: "MN-enriched miRNAs are depleted temporally in ALS rodent model and human patient spinal cord. MN-enriched miRNAs are depleted temporally in ALS rodent."— Presentation transcript:

1 MN-enriched miRNAs are depleted temporally in ALS rodent model and human patient spinal cord.
MN-enriched miRNAs are depleted temporally in ALS rodent model and human patient spinal cord. A, The MN-enriched miRNAs miR-218 and miR-138 are significantly depleted in ALS mouse (SOD1G93A) model spinal cord. This depletion occurs temporally and is maximized at end stage. n = 3–4. B, Pan-neuronal enriched miRNAs are not significantly depleted in ALS mouse model spinal cord, even at end stage. n = 3–4. C, MN-enriched miR-218 is significantly depleted in ALS rat model spinal cord and more so than the pan-neuronal miRNAs miR-382 and miR-672. n = 4–5. D, miR-218 is significantly depleted in human ALS patient autopsy spinal cord compared with age-matched controls. n = 4–10. Values are expressed as mean ± SEM. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ , one-way ANOVA with multiple comparisons (Dunnett's) (A), Student's unpaired, two-tailed t test (B, D), and two-way ANOVA (C). Relative expression is normalized to RNA input and endogenous miRNA control miR-24 (A, B) or U6 snRNA (C, D). Mariah L. Hoye et al. J. Neurosci. 2017;37: ©2017 by Society for Neuroscience

Download ppt "MN-enriched miRNAs are depleted temporally in ALS rodent model and human patient spinal cord. MN-enriched miRNAs are depleted temporally in ALS rodent."

Similar presentations

Figure 1. GLP-1 induces miR-132 and miR-212 expressions in pancreatic β-cells in vitro. A, miRNA expression profiling of GLP-1-treated INS-1 832/3 cells.

Figure 1. GLP-1 induces miR-132 and miR-212 expressions in pancreatic β-cells in vitro. A, miRNA expression profiling of GLP-1-treated INS-1 832/3 cells.
Differential expression of select miRNAs was validated in a second cohort of patients. Differential expression of select miRNAs was validated in a second.

Differential expression of select miRNAs was validated in a second cohort of patients. Differential expression of select miRNAs was validated in a second.
Transfer of miR-223 during neutrophil-epithelial cell interactions

Transfer of miR-223 during neutrophil-epithelial cell interactions
Fig. 2. Mechanism of PD-L1 down-regulation in NOD HSPCs.

Fig. 2. Mechanism of PD-L1 down-regulation in NOD HSPCs.
Characterization of DPR proteins in primary rat neurons and HEK293 cells. Characterization of DPR proteins in primary rat neurons and HEK293 cells. GFP,

Characterization of DPR proteins in primary rat neurons and HEK293 cells. Characterization of DPR proteins in primary rat neurons and HEK293 cells. GFP,
Figure 3 Age, pretreatment, sex, and leukopenia do not influence CD19+ cell repopulation Age, pretreatment, sex, and leukopenia do not influence CD19+

Figure 3 Age, pretreatment, sex, and leukopenia do not influence CD19+ cell repopulation Age, pretreatment, sex, and leukopenia do not influence CD19+
RGFP-966 increases H4K12 acetylation in HEK/APPsw cells.

RGFP-966 increases H4K12 acetylation in HEK/APPsw cells.
Tyrosine phosphorylation of mGluR1a in rat cerebellar neurons.

Tyrosine phosphorylation of mGluR1a in rat cerebellar neurons.
Fig. 1. Aberrant JNK pathway activation in mouse models of ALS and in spinal cord tissue from patients with sporadic ALS. Aberrant JNK pathway activation.

Fig. 1. Aberrant JNK pathway activation in mouse models of ALS and in spinal cord tissue from patients with sporadic ALS. Aberrant JNK pathway activation.
Sleep/wake phenotype of S551D mutant mice.

Sleep/wake phenotype of S551D mutant mice.
Activation of PBN and CeA by illuminating the hindpaw after PNI

Activation of PBN and CeA by illuminating the hindpaw after PNI
Fig. 4. Loss of DLK expression is neuroprotective in the SOD1G93A mouse model of ALS. Loss of DLK expression is neuroprotective in the SOD1G93A mouse model.

Fig. 4. Loss of DLK expression is neuroprotective in the SOD1G93A mouse model of ALS. Loss of DLK expression is neuroprotective in the SOD1G93A mouse model.
Patient-specific iPSCs show impaired neuronal maturation.

Patient-specific iPSCs show impaired neuronal maturation.
qRT-PCR validation of differential expression.

qRT-PCR validation of differential expression.
Volume 65, Issue 3, Pages (February 2010)

Volume 65, Issue 3, Pages (February 2010)
Light illumination excites Lamina I SDH neurons after PNI

Light illumination excites Lamina I SDH neurons after PNI
Toray microarray analysis of the four groups of patients (A) and in patients with calcium score >100 (B). Toray microarray analysis of the four groups.

Toray microarray analysis of the four groups of patients (A) and in patients with calcium score >100 (B). Toray microarray analysis of the four groups.
Verification of NEUROD2 binding to the conserved element within Stim1 intron 2. Verification of NEUROD2 binding to the conserved element within Stim1 intron.

Verification of NEUROD2 binding to the conserved element within Stim1 intron 2. Verification of NEUROD2 binding to the conserved element within Stim1 intron.
Supplementary Figure 5: Effect of S48168 on normalized organ and skeletal muscle weights after 12 weeks of treatment for all the experimental groups from.

Supplementary Figure 5: Effect of S48168 on normalized organ and skeletal muscle weights after 12 weeks of treatment for all the experimental groups from.
The 3′F allele does not recapitulate the systemic hyperimmune phenotypes associated with mir-146a deficiency. The 3′F allele does not recapitulate the.

The 3′F allele does not recapitulate the systemic hyperimmune phenotypes associated with mir-146a deficiency. The 3′F allele does not recapitulate the.

Similar presentations

Ads by Google